TAG:
G2 Intelligence
Experts Explain Evolving Ransomware Attacks
By Oscelle Boye | From the Volume XXXIII, No. 6 – May 04, 2026 Issue
CEO SUMMARY: Security industry reports suggest that ransomware attacks will only increase. Cybersecurity experts who have navigated high-profile ransomware incidents offer details on how modern criminal incursions happen in clinical laboratories, including early warning si…
May 4, 2026, Intelligence: Late-Breaking Lab News
By Janette Wider | From the Volume XXXIII, No. 6 – May 04, 2026 Issue
A multicenter study of Vitestro’s autonomous phlebotomy system, Aletta, points to a shift in how clinical labs approach blood collection. The ADOPT trial, conducted across outpatient settings in the Netherlands with additional US data, evaluated performance, safety, and patient experi…
Global IVD Woes in China Should Resonate with US Labs
By Mark Terry | From the Volume XXXIII, No. 3 – March 2, 2026 Issue
In vitro diagnostics (IVD) companies reported a mix of overall growth, with many noting continuing challenges in their diagnostics divisions for recent quarterly financial results. Thermo Fisher Scientific, QuidelOrtho, and Danaher reported the…
December 8, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 17 – December 8, 2025 Issue
For the next 46 months, a Georgia fraudster will stay behind bars after pleading guilty to charges he violated the Anti-Kickback Statute by arranging for medically unnecessary genetic tests. A judge sentenced Patrick C. Moore, Jr. on Dec. 2. Moore was also ordered to pay $7.2 million in…
National Lab Company Briefs
By Scott Wallask | From the Volume XXXII, No. 14 – October 6, 2025 Issue
Quest, Labcorp Push Alzheimer’s Test Quest Diagnostics and Labcorp are now offering Fujirebio’s Lumipulse test, the first Food and Drug Administration-cleared blood-based assay for con…
AI Hype in Labs: 6 Tips to Sniff Out the BS
By Scott Wallask | From the Volume XXXII, No. 11 – August 4, 2025 Issue
CEO SUMMARY: In the final entry of our artificial intelligence series, the co-founders of Sample Healthcare discuss how clinical labs can evaluate AI vendors effectively, with an emphasis on assessing technical credentials and quick proofs of concept. Armed with the right …
For AI Regulation, Look to Data Laws, FDA Action
By Scott Wallask | From the Volume XXXII, No. 10 – July 14, 2025 Issue
CEO SUMMARY: AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics. Few court cases exist yet that interpret AI use within clinical settings, but labs must watch how HIPAA and state laws wield influence. Vendor soft…
For Lab Veterans, It’s Time to Step into AI’s Shadow
By R. Lewis Dark | From the Volume XXXII, No. 9 – June 23, 2025 Issue
READING THROUGH THE FIRST INSTALLMENT OF THE DARK REPORT’S analysis about the state of artificial intelligence (AI) in clinical laboratories, this cantankerous observer found himself thinking about ChatGPT. Do I dare to use ChatGPT? Occasionally. …
Workers Use AI More than Lab Leaders Think
By Scott Wallask | From the Volume XXXII, No. 9 – June 23, 2025 Issue
CEO SUMMARY: In part one of an analysis about the state of AI in clinical laboratories, The Dark Report explores how frontline workers, especially younger ones, are using AI tools like ChatGPT far more than lab leaders. Recent reports elsewhere in the business world show e…
June 2, 2025, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXXII, No. 8 – June 2, 2025 Issue
Our sibling publication, G2 Intelligence, reported in May about a new Department of Justice (DOJ) memorandum that indicated prosecutors will seek to exercise fairness when deciding how to pursue fraud cases against clinical laboratories and other organizations. The DOJ emphasiz…
CURRENT ISSUE
Volume XXXIII, No. 10 – August 2026
In the August 2026 briefing, The Dark Report explains the relevance behind CMS potentially changing how it pays for “software as a medical service”. Other topics include a look into how health system executives view clinical labs, possible CLIA updates, and a 30/60/90-day approach to reducing reliance on traveling medical lab techs.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized